Search results for "FentaNYL Citrate"

showing 3 items of 3 documents

Oral trasmucosal fentanyl citrate for breakthrough pain treatment in cancer patients.

2012

Breakthrough cancer pain has been defined as a transitory increase in pain intensity that occurs either spontaneously or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain. The availability of supplemental doses of oral opioids, in addition to the continuous analgesic medication, is the main treatment suggested to manage pain flares.Oral transmucosal fentanyl citrate (OTFC) is the first product of a new generation of delivery systems, named rapid-onset opioids (ROOs), characterized by rapidity of effect and the short duration of analgesia. Controlled studies and long-term experience have shown that OTFC is an e…

PharmacologyClinical Trials as Topicbusiness.industryBreakthrough PainAnalgesicBreakthrough PainMouth MucosaCancerAdministration OralGeneral Medicinemedicine.diseaseFentaNYL CitratePain ladderAnalgesics OpioidFentanylAnesthesiaNeoplasmsmedicineEffective treatmentHumansPharmacology (medical)Onset of actionCancer painbusinessRandomized Controlled Trials as TopicExpert opinion on pharmacotherapy
researchProduct

686 EASE OF USE AND PREFERENCE FOR INTRANASAL FENTANYL SPRAY (INFS) VERSUS ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR BREAKTHROUGH CANCER PAIN

2009

medicine.medical_specialtyAnesthesiology and Pain MedicineIntranasal Fentanyl Spraybusiness.industryAnesthesiamedicineCancer painbusinessPreferenceFentaNYL CitrateSurgeryEuropean Journal of Pain
researchProduct

685 EFFICACY OF INTRANASAL FENTANYL SPRAY (INFS) VERSUS ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR BREAKTHROUGH CANCER PAIN: OPEN‐LABEL CROSSOVER …

2009

medicine.medical_specialtyAnesthesiology and Pain MedicineIntranasal Fentanyl Spraybusiness.industryAnesthesiamedicineOpen labelCancer painbusinessCrossover studyFentaNYL CitrateSurgeryEuropean Journal of Pain
researchProduct